Due to the inclement weather across much of the country, Medtronic deliveries are currently experiencing delays and there will be longer than normal hold times on the phone. Visit www.Diabetes.shop if you need to place an order, get a sensor or belt clip replacement, or check the status of your supply order.
It’s taken us longer than we initially expected to deliver an Android-compatible version of the MiniMed Connect accessory, but we are pleased that Medtronic customers using the MiniMed 530G and Revel systems, will have the first and only app enabling people with diabetes to view real-time glucose data on Android devices. (And we have learned a lot along the way to help us bring future Android apps to market faster.)
The MiniMed Connect app allows people with diabetes to stay connected to their care partners, by sending SmartGuard™ threshold suspend events, low glucose alerts, and other alerts and alarms that are not cleared by you, via text message. It also provides convenient, discreet access to key pump and sensor data right on your smartphone.
Many of you – whether you’re a person with diabetes, a d-mom, d-dad or other care partner – have told us how important it is for you to have better access to real-time pump and CGM data. This is why we’re so thrilled to share this news with you today.
And did you know that with better access to data, MiniMed Connect users and their doctors are able to make adjustments that can reduce highs and lows? That’s right – people using the MiniMed Connect app and CareLink software are seeing (on average):
2 fewer severe lows* per year
41 fewer severe highs* per year
66% are staying in range more often
The MiniMed Connect uploader is compatible with the MiniMed 530G system and MiniMed Revel system. It consists of three parts:
A small uploader which easily fits on a keychain or in a pocket
A smartphone app for the person with diabetes
A web app for care partners, enabling remote access to real-time data on any Web-connected device
The MiniMed® Connect App for Android is compatible with the following devices, running 5.0/5.1.1/5.1.2 (Lollipop) and Android 6.0/6.0.1/6.0.2 (Marshmallow)
Samsung Galaxy® S5/S6/S7
Samsung Galaxy S6 Edge® / S7 Edge
Samsung Galaxy S6 Edge+®
Samsung Galaxy Note®4/5
We have fully tested the MiniMed Connect app for Android on the devices above. If your Android device is not on the compatibility list above, but has Android 5.0 or 6.0, you can still try the MiniMed Connect accessory and app. (You will see a message that your device is not officially supported, and your app may display slightly differently than intended.) If you try the MiniMed Connect app on your device, you can always use our 30-day return policy if you experience any issues.
The MiniMed Connect App for iOS is compatible with the following Apple® devices running iOS 9 and iOS 9:
We hope you’re as excited as we are about MiniMed Connect! As always, we would like to hear what you think so be sure to tell us in the comments!
IMPORTANT SAFETY INFORMATION
The MiniMed Connect accessory is intended to provide a secondary display of CGM and insulin pump information on a suitable consumer electronic device to care partners and users of a MiniMed 530G system or Paradigm REAL-Time Revel system for the purposes of passive monitoring.
The MiniMed Connect app is not intended to replace the primary display of continuous glucose monitoring and insulin pump information on the primary display device. All therapy decisions should be based on blood glucose measurements obtained from a blood glucose meter. The MiniMed Connect app is not intended to receive information directly from the sensor or transmitter of the sensor-augmented pump system.
At Medtronic Diabetes our vision is to transform diabetes care together for greater freedom and better health. Each word in that statement is important – including the one “together”. We’re a group of passionate people working hard to make a big positive impact on the lives of those with diabetes. But we can’t do it alone. Collaboration is key. With healthcare providers, academic institutions, non-profits and other companies. And, most importantly, with you – the people who live with diabetes every day.